Li Dongjian, Sun Zhiguo, Ma Ling, Liu Shaohua
Department of Clinical Medicine, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, P.R. China.
Department of Plastic and Burn Surgery, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China.
Oncol Lett. 2023 Oct 31;26(6):536. doi: 10.3892/ol.2023.14122. eCollection 2023 Dec.
Scalp angiosarcoma (SA) is rare, accounting for <1% of soft tissue sarcomas, with a high degree of malignancy, a high recurrence rate and a poor prognosis. The best treatment strategy is uncertain. Therefore, it is essential to continuously refine treatment strategies and improve the prognosis of patients. Curative-intent surgery increases overall survival in patients with primary cutaneous angiosarcoma of the scalp and face, and radiation therapy combined with chemotherapy is now recommended for the curative treatment of patients who both can or cannot undergo surgery. The present case report is of an 87-year-old man hospitalised for the fifth time with SA. He had experienced four recurrences and previously underwent curative-intent surgery four times. However, the patient did not undergo radiotherapy or chemotherapy after any of the surgeries. A detailed report of the management of this case is presented along with a review of the relevant literature. It is hypothesised that patients with SA should receive a combination of radiotherapy and chemotherapy after surgery whenever possible, which may improve patient prognosis.
头皮血管肉瘤（SA）较为罕见，占软组织肉瘤的比例不到1%，具有高度恶性、高复发率和较差的预后。最佳治疗策略尚不确定。因此，不断完善治疗策略并改善患者预后至关重要。根治性手术可提高头皮和面部原发性皮肤血管肉瘤患者的总生存率，目前建议对能够或不能接受手术的患者采用放疗联合化疗进行根治性治疗。本病例报告的是一名87岁男性因SA第五次住院。他经历了四次复发，之前接受了四次根治性手术。然而，该患者在任何一次手术后均未接受放疗或化疗。本文介绍了该病例的详细管理报告，并对相关文献进行了综述。据推测，SA患者术后应尽可能接受放疗和化疗联合治疗，这可能会改善患者预后。
